v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 15 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Cash flows from operating activities:          
Net loss $ (26,871) $ (11,093) $ (61,360) $ (37,320)  
Adjustments to reconcile net loss to cash flows used in operating activities:          
Depreciation and amortization of property and equipment     9,131 7,757  
Amortization of intangible assets     20,067 22,795  
Amortization of debt issuance costs and original issue discount     1,476 1,401  
Stock-based compensation     10,786 8,775  
Deferred income taxes     (8,470) (8,984)  
Change in fair value of warrant liability     (912) (1,641)  
Foreign currency exchange losses     2,844 587  
Changes in operating assets and liabilities:          
Accounts receivable     10,395 4,578  
Inventory     (11,319) (2,820)  
Other operating assets     1,038 (186)  
Accounts payable     9,128 5,083  
Accrued expenses and other long-term liabilities     (13,187) (11,030)  
Deferred revenue     (3,114) 6,675  
Net cash used in operating activities     (33,497) (4,330)  
Cash flows from investing activities:          
Purchases of property and equipment     (7,368) (17,831)  
Purchases of software licenses     (553)    
Net cash used in investing activities     (7,921) (17,831)  
Cash flows from financing activities:          
Borrowings under revolving line of credit     15,000    
Principal payments on revolving line of credit     (15,000)    
Principal payments of term debt     (4,375) (1,750)  
Payment of debt issuance costs     (977)    
Proceeds from the exercise of stock options       6  
Payment of tax obligations related to vested stock awards and units     (4,980) (3,396)  
Repurchase of common stock     (824) (2,253) $ (9,800)
Net cash used in financing activities     (11,156) (7,393)  
Effect of exchange rate changes on cash and cash equivalents     (74) 1,349  
Net decrease in cash and cash equivalents     (52,648) (28,205)  
Cash, cash equivalents and restricted cash, beginning of year     98,131 90,479  
Cash, cash equivalents and restricted cash, end of period $ 45,483 $ 62,274 45,483 62,274 $ 45,483
Supplemental disclosure of cash flow information:          
Interest paid     17,526 19,167  
Income taxes paid     4,200 7,716  
Income tax refunds received     327 474  
Supplemental disclosure of non-cash investing activities:          
Capital expenditures incurred, but not yet paid     1,303 5,436  
Inventory transfers to property and equipment     549 874  
Software licenses purchased, but not yet paid     553    
Supplemental disclosure of non-cash financing activities:          
Warrant liability released to additional paid-in-capital       150  
Fair value of vested restricted and performance-based stock grants     $ 13,923 $ 11,253